HealthStream filings document the regulatory record for a Tennessee healthcare technology company listed on Nasdaq under HSTM. Its 8-K filings report quarterly and annual operating results, Regulation FD disclosures, dividend declarations, share repurchase programs, acquisitions and amendments to its revolving credit agreement.
The company’s proxy materials cover board matters, executive compensation, equity awards and shareholder voting items under its governance framework and incentive plans. Material-event filings also document executive appointments and related compensatory arrangements, while exhibits to current reports provide formal press releases and agreement summaries tied to HealthStream’s capital allocation, financing and workforce-technology operations.
RAPPUHN TERRY ALLISON reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc director Terry Allison Rappuhn reported a new equity award and her current shareholdings. She received 3,654 restricted share units (RSUs), each representing the contingent right to one share of common stock when the units vest.
The RSUs are subject to a three-year vesting schedule and vest annually in three equal installments beginning May 28, 2027, contingent on continued service. Following the reported transactions, she directly holds 7,243 shares of common stock and the 3,654 RSUs, reflecting a routine compensation-related grant rather than an open-market trade.
REBROVICK LINDA reported acquisition or exercise transactions in this Form 4 filing.
HEALTHSTREAM INC director Linda Rebrovick reported an equity award and updated holdings. She received a grant of 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock upon vesting. The RSUs vest over three years in three equal annual installments starting on May 28, 2027, contingent on continued service. Following this update, she holds 56,181 shares of common stock directly and 3,654 RSUs as a separate derivative position.
MCLAREN JEFFREY L reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc. director Jeffrey L. McLaren received a new equity award in the form of restricted share units. He was granted 3,654 RSUs, each representing the contingent right to receive one share of common stock upon vesting.
The RSUs are subject to a three-year vesting schedule, vesting annually in three equal installments beginning on May 28, 2027, contingent on continued service. Following this award, McLaren is reported as holding 22,600 shares of common stock directly, alongside the 3,654 RSUs.
Jahangir Amir Alex reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc director Amir Alex Jahangir reported a new equity award and his current holdings. He received 3,654 restricted share units (RSUs), each representing the contingent right to one share of common stock upon vesting. The RSUs follow a three-year vesting schedule, vesting in three equal annual installments beginning on May 28, 2027, contingent on continued service at the time of vesting. Following these transactions, he directly holds 3,257 shares of common stock and 3,654 RSUs linked to common stock.
DENT THOMPSON reported acquisition or exercise transactions in this Form 4 filing.
HEALTHSTREAM INC director Dent Thompson reported a new equity award. On May 28, 2026, he received 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock when the units vest.
The RSUs vest over three years in equal annual installments beginning May 28, 2027, and are contingent on his continued service. Following this filing, Thompson holds 136,827 shares of common stock directly, in addition to the 3,654 RSUs.
Beard Charles Jr. reported acquisition or exercise transactions in this Form 4 filing.
HealthStream Inc. director Charles Jr. Beard reported an equity compensation grant rather than a stock trade. On May 28, 2026, he received 3,654 restricted share units (RSUs), each representing the right to receive one share of HealthStream common stock when it vests.
The RSUs follow a three-year vesting schedule, vesting in three equal annual installments beginning May 28, 2027, and require continued service through each vesting date. This filing does not show any open-market purchases or sales, and Beard’s post-transaction direct RSU holding from this grant is 3,654 units.
GORDON FRANK reported acquisition or exercise transactions in this Form 4 filing.
HealthStream director Frank Gordon reported new equity compensation awards rather than open-market trades. On May 28, 2026, he received 1,482 shares of common stock at $24.63 per share, which he elected to take in stock instead of cash for his Board service. Following this award, his direct common stock holdings total 212,404 shares.
He was also granted 3,654 restricted share units (RSUs), each representing the right to receive one share of common stock upon vesting. These RSUs vest over a three-year schedule, in three equal annual installments beginning on May 28, 2027, contingent on continued service. The filing also lists several indirect ownership accounts, including family trusts, custodial accounts for minor children, and entities such as The Joel Company and Crofton Capital.
HealthStream Inc. director Linda Rebrovick reported an open-market sale of 2,000 shares of common stock at $25.00 per share on May 28, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025. After this sale, she directly holds 56,181 HealthStream shares.
HealthStream, Inc. reported the final voting results from its May 28, 2026 annual meeting of shareholders. Director nominees received the following votes: A. Alex Jahangir had 22,452,989 votes for, 2,421,416 withheld, and 2,654,245 broker non-votes; Jeffrey L. McLaren had 14,484,114 for, 10,390,291 withheld, and 2,654,245 broker non-votes; and Linda Rebrovick had 23,316,490 for, 1,557,915 withheld, and 2,654,245 broker non-votes.
Shareholders also voted on two additional proposals. One proposal received 27,171,627 votes for, 355,926 against, and 1,097 abstentions with no broker non-votes. Another proposal received 23,852,346 votes for, 1,019,058 against, 3,001 abstentions, and 2,654,245 broker non-votes. Directors not up for election continue to serve on the Board.